| Autor: |
Montesinos, Pau, Ballesteros, Joan, Martínez-Cuadrón, David, Martínez-López, Joaquín, Serrano, Josefina, Perez de Oteyza, Jaime, Fernández, Pascual, Rodriguez-Macías, Gabriela, Vidriales, Mª Belén, Herrera, Pilar, Tormo, Mar, Bergua, Juan, García, Raimundo, Vives, Susana, Fernández, Mª Ángeles, Lavilla, Esperanza, Jimenez, Santiago, Pérez-Simón, Jose Antonio, Simiele, Adriana, González, Ataulfo, González, Bernardo J., Burgaleta, Carmen, López, Juan Antonio, Bethancourt, Concepción, Bautista, Guiomar, Alonso, Arancha, Colorado, Mercedes, Sierra, Jordi, Navas, Begoña, Hernández-Rivas, José Angel, Vera, Juan Antonio, Amador, Mª Lourdes, Cordoba, Raúl, de la Fuente, Adolfo, Ramos, Fernando, Cerveró, Carlos Javier, Rayón, Consolación, Salamero, Olga, Martí, Edelmira, López, Aurelio, Olavé, Teresa, Gaspar, Marta, Gorrochategui, Julian, Rojas, José Luis, Gomez, Cristina, Hernández, Pilar, Robles, Alicia, Ortega, Ignacio, Villoria, Jesús, Moscardó, Federico, Troconiz, Iñaki, Sanz, Miguel A. |
| Zdroj: |
Blood; December 2015, Vol. 126 Issue: 23 p4837-4837, 1p |
| Abstrakt: |
Background: We have overcome the limitations of 40 years of ex vivo testing. The aim of this study is to determine the ability of Vivia's novel test to predict the complete remission (CR) rates after induction chemotherapy with cytarabine (Ara-C) and idarubicin (Ida) in 1stline AML. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
